Ezra Cohen, MD, FRCPSC, FASCO, discusses the most important parts of successfully managing toxicities related to treatment with immunotherapy.
Ezra Cohen, MD, FRCPSC, FASCO, professor of medicine, associate director, translational science, Moores Cancer Center, University of California San Diego, discusses the most important parts of successfully managing toxicities related to treatment with immunotherapy.
Cohen says first, patients need to be educated on the toxicities that could present themselves and should notify their physician immediately should any symptoms appear. Cohen also says that the earlier the symptoms are seen, the easier it is to manage these toxicities and avoid them from escalating to life-threatening situations.
Survivorship Care Promotes Evidence-Based Approaches for Quality of Life and Beyond
March 21st 2025Frank J. Penedo, PhD, explains the challenges of survivorship care for patients with cancer and how he implements programs to support patients’ emotional, physical, and practical needs.
Read More